1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Product Pipeline Analysis
3.9. Incidence and Prevalence Analysis
3.10. Patent Analysis
4. TECHNOLOGICAL OUTLOOK
5. LAB-ON-A-CHIP DIAGNOSTIC SYSTEMS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2 Instruments
5.3. Reagents & Kits
5.4. Software & Services
6. LAB-ON-A-CHIP DIAGNOSTIC SYSTEMS MARKET BY TECHNOLOGY
6.1. Introduction
6.2. Microfluidics
6.3. Polymerase Chain Reaction (PCR)
6.4. Immunoassays
6.5. Electrophoresis
6.6. Biosensors
7. LAB-ON-A-CHIP DIAGNOSTIC SYSTEMS MARKET BY APPLICATION
7.1. Introduction
7.2. Clinical Diagnostics
7.3. Drug Discovery
7.4. Genomics & Proteomics
7.5. Point-of-Care Testing
7.6. Environmental Testing
8. LAB-ON-A-CHIP DIAGNOSTIC SYSTEMS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific
10.2. Danaher Corporation
10.3. Agilent Technologies
10.4. Bio-Rad Laboratories
10.5. Abbott Laboratories
10.6. PerkinElmer
10.7. Standard BioTools
10.8. Dolomite Microfluidics
10.9. Micronit Microtechnologies
10.10. Fluxergy
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations